<DOC>
	<DOCNO>NCT03000101</DOCNO>
	<brief_summary>The aim research study effect pomegranate juice calprotectin level patient suffer inflammatory bowel disease ( IBD ) clinical remission . Fecal calprotectin level , surrogate marker mucosal inflammation , measure baseline 12 week later ( end intervention ) . Systemic mucosal change biochemical molecular inflammatory response marker also assess .</brief_summary>
	<brief_title>Study Role Pomegranate Juice Ellagitannins Modulation Inflammation Inflammatory Bowel Diseases</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Patients Ulcerative Colitis ( diagnosed base clinic , endoscopic , histologic criterion ) clinical remission ( SCCAI = 0 ) least three month stable therapy ( without therapeutic modification three previous month ) mesalazine , immunomodulators and/or biologics . Patients affect Crohn 's Disease , particularly involve sigmoid colon rectum ( diagnosed base clinic , endoscopic , histologic criterion ) clinical remission ( CDAI &lt; 150 ) least three month stable therapy ( without therapeutic modification three previous month ) mesalazine A , immunomodulators and/or biologics . Fecal calprotectin baseline ≥ 100 μg/g . Signed informed consent . Patients affect Ulcerative Colitis Crohn 's Disease severe endoscopic disease activity ( Ulcerative Colitis : Mayo Endoscopic Score = 3 ; Crohn 's Disease : Simple Endoscopic Score SESCD &gt; 15 ) . Patients steroid therapy two previous month . Patients therapy warfarin anticoagulant . Known suppose hypersensitivity fruit and/or juice pomegranate . Women fertile age refuse use contraceptive specify study ( oral contraception , IUD ) breastfeed woman . Diabetic patient patient severe clinical condition investigator consider contraindicate patient participation study . Therapy modification and/or assumption experimental therapy within three month study inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Colitis</keyword>
	<keyword>Colitis , Ulcerative</keyword>
	<keyword>Colonic Diseases</keyword>
	<keyword>Crohn Disease</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Fruit</keyword>
	<keyword>Fruit Vegetable Juices</keyword>
	<keyword>Gastroenteritis</keyword>
	<keyword>Gastrointestinal Diseases</keyword>
	<keyword>Humans</keyword>
	<keyword>Hydrolysable Tannins</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Inflammatory Bowel Diseases</keyword>
	<keyword>Intestinal Diseases</keyword>
	<keyword>Punicaceae</keyword>
</DOC>